Salem Investment Counselors Inc. Purchases 3,125 Shares of Intuitive Surgical, Inc. (NASDAQ:ISRG)

Financial News Live · Feb 6, 2023 00:51

Salem Investment Counselors Inc. raised its position in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG – Get Rating) by 5.9% in the third quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 55,763 shares of the medical equipment provider's stock after purchasing an additional 3,125 shares during the period. Salem Investment Counselors Inc.'s holdings in Intuitive Surgical were worth $10,452,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other institutional investors and hedge funds have also bought and sold shares of the company. Bogart Wealth LLC increased its holdings in shares of Intuitive Surgical by 70.1% in the 3rd quarter. Bogart Wealth LLC now owns 148 shares of the medical equipment provider's stock valued at $28,000 after acquiring an additional 61 shares during the period. Larson Financial Group LLC grew its stake in Intuitive Surgical by 196.1% during the 2nd quarter. Larson Financial Group LLC now owns 151 shares of the medical equipment provider's stock valued at $30,000 after purchasing an additional 100 shares during the last quarter. Gleason Group Inc. grew its stake in Intuitive Surgical by 111.1% during the 3rd quarter. Gleason Group Inc. now owns 190 shares of the medical equipment provider's stock valued at $36,000 after purchasing an additional 100 shares during the last quarter. JFS Wealth Advisors LLC lifted its holdings in shares of Intuitive Surgical by 82.5% in the 2nd quarter. JFS Wealth Advisors LLC now owns 188 shares of the medical equipment provider's stock valued at $38,000 after buying an additional 85 shares during the period. Finally, CoreCap Advisors LLC acquired a new position in shares of Intuitive Surgical in the 2nd quarter valued at about $45,000. 81.96% of the stock is owned by institutional investors.

Get Intuitive Surgical alerts:

Analyst Upgrades and Downgrades

A number of research firms recently weighed in on ISRG. Mizuho reduced their price target on Intuitive Surgical from $245.00 to $240.00 in a report on Wednesday, January 25th. Morgan Stanley decreased their price target on Intuitive Surgical from $290.00 to $265.00 and set an "equal weight" rating on the stock in a research note on Wednesday, January 25th. Jefferies Financial Group assumed coverage on Intuitive Surgical in a research note on Wednesday, October 12th. They issued a "hold" rating and a $210.00 price objective on the stock. Wells Fargo & Company cut their price target on Intuitive Surgical from $305.00 to $289.00 and set an "overweight" rating on the stock in a research note on Wednesday, January 25th. Finally, Piper Sandler raised their price objective on Intuitive Surgical from $260.00 to $265.00 and gave the stock an "overweight" rating in a report on Wednesday, October 19th. Six investment analysts have rated the stock with a hold rating and thirteen have assigned a buy rating to the company. Based on data from MarketBeat.com, Intuitive Surgical presently has an average rating of "Moderate Buy" and a consensus target price of $273.83.

Intuitive Surgical Stock Performance

Intuitive Surgical stock traded down $6.22 during trading on Friday, reaching $254.68. 1,691,448 shares of the company's stock were exchanged, compared to its average volume of 2,011,179. The company's 50-day moving average is $262.77 and its two-hundred day moving average is $236.24. Intuitive Surgical, Inc. has a 52-week low of $180.07 and a 52-week high of $308.97. The firm has a market cap of $90.00 billion, a price-to-earnings ratio of 69.58, a PEG ratio of 5.05 and a beta of 1.28.

Intuitive Surgical (NASDAQ:ISRG – Get Rating) last announced its quarterly earnings results on Tuesday, January 24th. The medical equipment provider reported $1.23 earnings per share for the quarter, missing analysts' consensus estimates of $1.25 by ($0.02). Intuitive Surgical had a return on equity of 11.27% and a net margin of 21.25%. The business had revenue of $1.66 billion for the quarter, compared to analysts' expectations of $1.66 billion. During the same period last year, the company posted $1.30 earnings per share. The firm's revenue for the quarter was up 6.7% on a year-over-year basis. Analysts anticipate that Intuitive Surgical, Inc. will post 4.22 EPS for the current year.

Insiders Place Their Bets

In other Intuitive Surgical news, Director Amal M. Johnson sold 6,375 shares of the business's stock in a transaction on Tuesday, November 8th. The shares were sold at an average price of $239.36, for a total value of $1,525,920.00. Following the transaction, the director now owns 11,224 shares in the company, valued at approximately $2,686,576.64. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. In other Intuitive Surgical news, Director Amal M. Johnson sold 6,375 shares of the business's stock in a transaction on Tuesday, November 8th. The shares were sold at an average price of $239.36, for a total value of $1,525,920.00. Following the transaction, the director now owns 11,224 shares in the company, valued at approximately $2,686,576.64. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, EVP Robert Desantis sold 1,629 shares of the business's stock in a transaction on Friday, January 27th. The stock was sold at an average price of $250.00, for a total transaction of $407,250.00. Following the completion of the transaction, the executive vice president now owns 6,769 shares in the company, valued at approximately $1,692,250. The disclosure for this sale can be found here. 0.90% of the stock is currently owned by company insiders.

Intuitive Surgical Company Profile

(Get Rating)

Intuitive Surgical, Inc engages in the development, manufacture, and marketing of da Vinci Surgical Systems, and related instruments and accessories for invasive surgery. Its products include Da Vinci and Ion. The company was founded by Frederic H. Moll, John Gordon Freund, and Robert G. Younge in November 1995 and is headquartered in Sunnyvale, CA.

Salem Investment Counselors Inc. Purchases 3,125 Shares of Intuitive Surgical, Inc. (NASDAQ:ISRG)

Analyst Upgrades and Downgrades

Intuitive Surgical Stock Performance

Insiders Place Their Bets

Intuitive Surgical Company Profile

See Also

Risk Disclaimer